Literature DB >> 20938925

Social recognition assay in the rat.

Joanne R Mathiasen1, Amy DiCamillo.   

Abstract

Neuropsychiatric disorders encompass a broad patient population in a variety of disease states across all age groups and are often accompanied by deficits in short-term/working memory. However, most preclinical models that allow for an assessment of cognitive enhancement do not provide robust behavioral readouts with a level of throughput sufficient to support modern drug discovery efforts. The rat social recognition assay presented in this unit is one exception that has been increasingly employed to test new chemical entities for enhancing cognitive activity. The test is simple in design and takes advantage of the spontaneous behavior of rats to investigate conspecifics. The protocol in this unit is designed to evaluate the effects of a test substance on the short-term/working memory of adult male rats employing 30-min or 2-hr pretreatment times.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20938925     DOI: 10.1002/0471142301.ns0805is53

Source DB:  PubMed          Journal:  Curr Protoc Neurosci        ISSN: 1934-8576


  3 in total

1.  Epobis is a Nonerythropoietic and Neuroprotective Agonist of the Erythropoietin Receptor with Anti-Inflammatory and Memory Enhancing Effects.

Authors:  Oksana Dmytriyeva; Stanislava Pankratova; Irina Korshunova; Peter S Walmod
Journal:  Mediators Inflamm       Date:  2016-11-21       Impact factor: 4.711

Review 2.  Roadbumps at the Crossroads of Integrating Behavioral and In Vitro Approaches for Neurotoxicity Assessment.

Authors:  G Jean Harry; Sandra McBride; Shannah K Witchey; Sakina Mhaouty-Kodja; Alain Trembleau; Matthew Bridge; Anna Bencsik
Journal:  Front Toxicol       Date:  2022-02-25

3.  Precision Medicine in Alzheimer's Disease: Investigating Comorbid Common Biological Substrates in the Rat Model of Amyloid Beta-Induced Toxicity.

Authors:  Maria Grazia Morgese; Maria Bove; Lorenzo Di Cesare Mannelli; Stefania Schiavone; Anna Laura Colia; Stefania Dimonte; Emanuela Mhillaj; Vladyslav Sikora; Paolo Tucci; Carla Ghelardini; Luigia Trabace
Journal:  Front Pharmacol       Date:  2022-01-03       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.